Singapore Aesthetic Injectable Market Size & Outlook

The aesthetic injectable market in Singapore is expected to reach a projected revenue of US$ 58.7 million by 2033. A compound annual growth rate of 10.6% is expected of Singapore aesthetic injectable market from 2026 to 2033.
Revenue, 2025 (US$M)
$26.3
Forecast, 2033 (US$M)
$58.7
CAGR, 2026 - 2033
10.6%
Report Coverage
Singapore

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Singapore aesthetic injectable market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Singapore aesthetic injectable market highlights

  • The Singapore aesthetic injectable market generated a revenue of USD 26.3 million in 2025 and is expected to reach USD 58.7 million by 2033.
  • The Singapore market is expected to grow at a CAGR of 10.6% from 2026 to 2033.
  • In terms of segment, hyaluronic acid was the largest revenue generating product in 2025.
  • PN/PDRN is the most lucrative product segment registering the fastest growth during the forecast period.


Aesthetic injectable market data book summary

Market revenue in 2025USD 26.3 million
Market revenue in 2033USD 58.7 million
Growth rate10.6% (CAGR from 2026 to 2033)
Largest segmentHyaluronic acid
Fastest growing segmentPN/PDRN
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationCollagen and PMMA Microspheres, Hyaluronic Acid, Calcium Hydroxylapatite (CaHA), PLLA, PCL, PN/PDRN, Botulinum Toxin (Botox)
Key market players worldwideIpsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc


Other key industry trends

  • In terms of revenue, Singapore accounted for 0.2% of the global aesthetic injectable market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, China aesthetic injectable market is projected to lead the regional market in terms of revenue in 2033.
  • Vietnam is the fastest growing regional market in Asia Pacific and is projected to reach USD 72.1 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Aesthetic Injectable Market Companies

Name Profile # Employees HQ Website
Ipsen SA View profile 5325 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 https://www.ipsen.com
Medytox View profile 501-1000 Seoul, Seoul-t'ukpyolsi, South Korea, Asia http://www.medytox.com/page/company_en?site_id=en
Sinclair Pharma plc View profile 501-1000 London, England, United Kingdom, Europe http://www.sinclairpharma.com/
Prollenium Medical Technologies View profile 101-250 Richmond Hill, Ontario, Canada, North America https://prollenium.com
Suneva Medical View profile 101-250 San Diego, California, United States, North America http://sunevamedical.com
Merz Pharma View profile 5001-10000 Deutsch, Sachsen, Germany, Europe http://www.merz.com
Revance Therapeutics Inc View profile 597 1222 Demonbreun Street, Suite 2000, Nashville, TN, United States, 37203 https://www.revance.com
Galderma Group AG Registered Shares View profile - Zählerweg 10, Zug, Switzerland, 6300 https://www.galderma.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com

Singapore aesthetic injectable market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aesthetic injectable market will help companies and investors design strategic landscapes.


Hyaluronic acid was the largest segment with a revenue share of 78.33% in 2025. Horizon Databook has segmented the Singapore aesthetic injectable market based on collagen and pmma microspheres, hyaluronic acid, calcium hydroxylapatite (caha), plla, pcl, pn/pdrn, botulinum toxin (botox) covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Singapore aesthetic injectable market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Singapore aesthetic injectable market databook

  • Our clientele includes a mix of aesthetic injectable market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Singapore aesthetic injectable market, including forecasts for subscribers. This country databook contains high-level insights into Singapore aesthetic injectable market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Singapore Product - Aesthetic Injectable Market, 2025 - 2033 (US$M)

Singapore Aesthetic Injectable Market Share, 2025 & 2033 (US$M)

Singapore Product - Aesthetic Injectable Market, 2025 - 2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online